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Abstract
Background:  Active surveillance for transmissible spongiform encephalopathies in small
ruminants has been an EU regulatory requirement since 2002. A number of European countries
have subsequently reported cases of atypical scrapie, similar to previously published cases from
Norway, which have pathological and molecular features distinct from classical scrapie. Most cases
have occurred singly in flocks, associated with genotypes considered to be more resistant to
classical disease. Experimental transmissibility of such isolates has been reported in certain ovinised
transgenic mice, but has not previously been reported in the natural host. Information on the
transmissibility of this agent is vital to ensuring that disease control measures are effective and
proportionate.
Results: This report presents the successful experimental transmission, in 378 days, of atypical
scrapie to a recipient sheep of homologous genotype with preservation of the pathological and
molecular characteristics of the donor. This isolate also transmitted to ovinised transgenic mice
(Tg338) with a murine phenotype indistinguishable from that of Nor 98.
Conclusion: This result strengthens the opinion that these cases result from a distinct strain of
scrapie agent, which is potentially transmissible in the natural host under field conditions.
Background
TSE in sheep have been recorded for more than 250 years
in the form of classical scrapie. In classical scrapie, there is
a clear link between susceptibility and sheep genotype [1],
and many countries are now implementing disease con-
trol programmes based on breeding for resistance. Host
genotype also appears to affect to some extent the ulti-
mate pathological presentation of the disease [2-4] as do
specific scrapie 'strains' [5] and this complex interaction is
not yet clearly understood, although it is widely accepted
that several variants of classical scrapie exist in the field.
However, in 2003, a newly identified form of scrapie
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(Nor98) was reported in Norway, which was distinct from
the established range of classical scrapie phenotypes [6].
In 2002, regulatory requirements for active TSE surveil-
lance were implemented across the EU, and a number of
countries have subsequently reported atypical isolates,
full details of which can be found in the EFSA opinion of
2005 [7]. It has also recently been reported for the first
time in the Southern hemisphere, in a sheep native to the
Falkland Islands [8].
The current minimum scrapie control measures within
the EU require selective culling within a flock, based on
genotype susceptibility to classical scrapie. However, the
susceptible genotype range for atypical cases differs from
that of classical disease [7,9-11] with most cases occurring
in genotypes associated with relative resistance to classical
scrapie, and so other measures need to be considered in
flocks where only atypical scrapie is identified. This is par-
ticularly pertinent given the epidemiology of atypical
scrapie, with the majority of cases occurring as singletons
within a flock when arguably the existing culling policies
will achieve little additional control.
It has already been established that such atypical isolates
can transmit to over-expressing ovinised transgenic mice
(Tg338, [12]) but it is crucial to the formulation of control
policies to establish whether or not this is a stable strain
of TSE which can transmit within the natural host.
The route of natural transmission for TSE is still unclear,
so the approach taken to establishing transmissibility of
such an agent is generally performed in a number of steps.
Initial species susceptibility is established by transmission
via intracerebral inoculation, which optimises the deliv-
ery of the agent to the target organ, and minimises any
reduction in efficiency of transmission resulting from a
more peripheral route. Once such susceptibility is estab-
lished, the outcome of challenges by more natural routes
(e.g. oral challenge) is more informative.
This report presents the first successful intracerebral trans-
mission of atypical scrapie within the natural host.
Results
A 5 month old Cheviot sheep (with PrP genotype
A136H154Q171/A136H154Q171 [1]) was inoculated intracere-
brally with cerebellum from a case of atypical scrapie (5
year old Portland sheep, genotype AHQ/AHQ) identified
through the fallen stock active surveillance programme.
The recipient sheep was killed 378 dpi with signs of a neu-
rological disease. These comprised behavioural changes
(separation from others, confusion when the pen was
entered, compulsive behaviour, such as nibbling move-
ments of the lips (see Additional File 1) and circling clock-
wise (see Additional File 2), locomotor changes (mild
ataxia with proprioceptive deficits) and loss of weight
(16% in the preceding 6–8 weeks) and bodily condition.
Pruritus was not a feature of this disease. The clinical find-
ings were suggestive of a diffuse brain disease, which par-
ticularly involved the forebrain. The clockwise circling
suggested an asymmetric lesion, but it was not possible to
investigate this further, because only one half of the brain
was fixed for histopathology. Behavioural changes were
first reported by animal care staff at 314 dpi.
A Western blot (Figure 1) prepared using the BioRad
TeSeE™ revealed a banding pattern consistent with Nor98
[6], with a distinct low molecular mass band at approxi-
mately 12 kD. This pattern matched exactly the banding
pattern of the donor sheep, and was consistent with the
molecular characteristics of other UK atypical scrapie field
isolates run on the same gel.
Comparison of the distribution and type of PrPSc immu-
nolabelling in the brains of both the donor and recipient
animals revealed preservation of the immunopathologi-
cal features following transmission (Figure 2). Immunola-
belling in the medulla at the level of the obex was
minimal, and confined to fine granular deposits in the
nucleus of the spinal tract of the trigeminal nerve. Fine
granular PrPSc was distributed widely throughout the grey
BioRad Western Blot (10 min Detection) Figure 1
BioRad Western Blot (10 min Detection). 15 µl of 
sample is loaded in each lane, giving a tissue equivalent of 
0.02 g. Each sample is run in duplicate in adjacent lanes. Lanes 
1 and 2 UK passive surveillance atypical scrapie (ARQ/AHQ; 
cortex). Lanes 3 and 4 UK passive surveillance atypical 
scrapie (AHQ/ARR; cortex). Lanes 5 and 6 UK active surveil-
lance atypical scrapie (AHQ/ARR; medulla). Lanes 7 and 8 
Donor sheep. UK active surveillance atypical scrapie (AHQ/
AHQ; medulla). Lanes 9 and 10 Recipient sheep. Experimen-
tal atypical scrapie (AHQ/AHQ; medulla). Lane 11 UK classi-
cal scrapie positive control (VRQ/VRQ; medulla). Lane 12 
Swedish Nor98 positive control (kindly supplied by Dr D 
Gavier-Widen, SVA, Sweden). Lane 13 UK bovine BSE posi-
tive active surveillance case control (brainstem). Lanes M 
Molecular mass markers.
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matter of the cerebellar and cerebral cortices, and the
neuropil of the basal ganglia and thalamus in both donor
and recipient. Much less labelling was seen in the mid-
brain and medullary regions. Globular or semi-globular
staining in the white matter, possibly associated with oli-
godendrocytes, was also widely distributed throughout
the brain, again with relative sparing of the brainstem
regions. There was no intracellular labelling seen in either
case, which is consistent with observations in other atypi-
cal scrapie field cases, and different from classical scrapie
(Simmons and Spiropoulos, personal observations) Apart
from a small amount of vacuolation in the molecular
layer of the cerebellum in the recipient animal, there was
no TSE-associated vacuolation observed in either animal.
No immunolabelling could be demonstrated in the LRS
areas examined in the recipient animal (mesenteric lymph
node, palatine tonsil, spleen, Peyer's patches of the distal
ileum and nictitating membrane), which is in keeping
with the limited observations in a similar range of LRS tis-
sues which have been made in five animals naturally
affected with atypical scrapie (MM Simmons, unpub-
lished observations). However, this might also be par-
tially attributable to the intracerebral route, since only
very restricted LRS involvement was present in the classi-
cal scrapie positive control, which is contrary to observa-
tions in natural disease, and following oral challenge [13].
A second animal, also of the AHQ/AHQ genotype, which
received an equivalent challenge with the same inoculum
is still alive and healthy at more than 900 dpi (as at:June
2007).
Transmission of the source inoculum to Tg338 mice,
within a separate project (J Spiropoulos and PC Griffiths,
unpublished observations), was successful, with an incu-
bation period of 210 ± 4.8 days and a histological lesion
profile and PrPSc  distribution pattern consistent with
Nor98 and French discordant cases [12].
Discussion
To our knowledge this is the first report of the successful
experimental transmission of atypical scrapie within the
natural host. The retention of the molecular and patho-
logical characteristics of the scrapie agent following this
experimental transmission supports the hypothesis that
disease in the donor animal was caused by a stable strain
of the TSE agent which has phenotypic characteristics dis-
tinct from those associated with classical scrapie.
Although clinical signs were not recorded from the donor
animal because it presented dead (fallen stock), the signs
seen in the challenged animal were consistent with those
reported for the small number of passive surveillance
cases so far identified in the UK [14,15] and elsewhere
[6,16], which were characterised by gait abnormalities,
abnormal behaviour and a relative lack of pruritic signs.
The transmission characteristics of atypical scrapie from
different countries in Tg338 mice [12] and emerging data
from similar transmissions of the isolate in this report
indicate that at least one strain of atypical scrapie compat-
ible with/indistinguishable from Nor98 is widespread
across Europe, despite its relatively recent identification.
Although it has now been demonstrated to be experimen-
tally transmissible within and between species via the
intracerebral route, there is little epidemiological evidence
for ease of transmission of this strain under field condi-
tions, where scrapie is most likely transmitted via the oral
route. This raises the question of how it came to be so geo-
graphically widespread. One hypothesis is that this repre-
Distribution and type of PrP immunolabelling in the donor  (A) and the recipient sheep (B) Figure 2
Distribution and type of PrP immunolabelling in the 
donor (A) and the recipient sheep (B). Red = fine par-
ticulate staining of the neuropil. Green = coarse particulate/
globular staining in the white matter. i) medulla oblongata 
(level of the obex); ii) rostral medulla/cerebellum; iii) caudal 
midbrain; iv) rostral midbrain; v) thalamus/occipital cortex/
hippocampus; vi) rostral thalamus/hypothalamus/parietal cor-
tex; vii) frontal cortex/basal ganglion.
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sents a spontaneous genetic disease in sheep similar to the
familial forms of TSE in man (e.g. GSS, familial CJD and
FFI etc.), in which the resultant disease can subsequently
be transmitted experimentally [17,18].
Horizontal transmission of classical scrapie has been
shown to occur in adult sheep exposed to an affected flock
[19] and even in animals which have had contact only
with a contaminated environment (GI Dexter and SJ Bell-
worthy, personal communication). The environmental
persistence of the classical scrapie agent is also supported
by epidemiological evidence from Icelandic repopulation
studies [20,21]. However, the low molecular mass (<14
kD) band of PrPSc seen in Western blots of atypical isolates
is associated with a reduction in PK resistance of this dis-
ease-associated protein. It is possible that this relative pro-
tease susceptibility may make the agent less robust in field
conditions and thereby reduce the extent to which it is
transmissible by natural routes, and so limit the number
of cases. It could be argued that this in turn supports the
hypothesis that the natural disease may arise spontane-
ously. However, although genetic studies have indicated a
PrP genotype host range for atypical scrapie which, for the
majority of cases, is almost fully distinct from that of the
classical forms of disease, they have not identified a single
genetic feature (such as the point mutations in some
human forms [22]) which might account for this.
This relative PrPSc fragility [23] compared to the PrPSc in
classical scrapie, may also account for the total absence of
intracellular PrPSc  immunolabelling. The different PK
cleavage sites in PrP associated with different strains of
TSE infecting small ruminants can be used to differentiate
them, both in blots and by immunohistochemistry. Intra-
cellular immunostaining is significantly reduced in sheep
infected with BSE compared to classical scrapie, when the
appropriate monoclonal antibodies are applied, and it
has been speculated that this demonstrates a partial diges-
tion of the PrPSc molecule by the endogenous proteases
within the cells [24]. If the PrPSc is more protease sensitive,
then this loss of intracellular immunolabelling even with
an antibody to the core of the protein (such as MAb
2G11) might indicate that cells can more effectively
catabolise this abnormal form of the protein than more
'classical' forms, and therefore succumb to clinical disease
much later, if at all. This may also account for the appar-
ent absence of disease-related PrPSc in lymphoid tissues. It
is interesting to note that in familial CJD (E200K muta-
tion) also, PrP labelling was seen as a uniformly fine
deposit throughout all cortical layers [25].
This study confirms that 'atypical scrapie' is transmissible
within the natural host species, via the intracerebral route,
without alteration of the pathological and molecular char-
acteristics. This is the first report from a larger study which
will explore more widely the effect of the PrP gene on the
experimental susceptibility and resultant phenotype fol-
lowing intracerebral or oral challenge with this type of
scrapie isolate.
Conclusion
At present the significance of this result, in terms of the
transmissibility or pathogenicity under 'field conditions'
of this agent strain in any species remains speculative, but
it supports the need for appropriate control measures pro-
tecting both the animal and the human food chain to
encompass atypical scrapie cases specifically.
Methods
Inoculum preparation and inoculation
This experimental case is part of a larger study involving
oral as well as intracerebral routes of challenge. The phase
of this study which involved intracerebral challenge is
described here briefly for context. Four atypical isolates
identified through active surveillance were used for this
study. Two 'donor' animals were of the AHQ/AHQ geno-
type, and two were ARR/ARR. Material from each donor
animal was prepared as a 10% homogenate in normal
saline, checked for microbiological sterility and treated by
antibiotic (ampicillin, or gentamycin (+/- heat if
required)) prior to use. One ml of each homogenate was
inoculated intracerebrally into two homologous and two
'classically susceptible' (ARQ/VRQ) recipient sheep, all
derived from the VLA New Zealand-derived flock, and
ranging from 5.5 to 11 months old at the time of inocula-
tion.
All inoculations were carried out under general anaesthe-
sia, and in accordance with the UK Animal (Scientific Pro-
cedures) Act 1986, under Licence from the UK
Government Home Office (Project licence no: 70/5780).
Such licence is only granted following approval by the
internal VLA ethical review process as mandated by the
Home Office.
One ARQ/VRQ classical scrapie case (into two ARQ/VRQ
animals) was used as a positive control. Both recipient
sheep succumbed to disease at 537 and 605 dpi respec-
tively. A further positive control was provided by using a
VRQ/VRQ classical scrapie case inoculated into a VRQ/
VRQ recipient animal which developed clinical disease
(pruritus, ataxia and weight loss) at 126 dpi. Brain from
one ARR/ARR animal from the VLA New Zealand-derived
flock was inoculated into an ARQ/VRQ recipient as a neg-
ative control. This animal died of intercurrent disease at
911 dpi, and was negative. All sheep are kept indoors and
in fully segregated groups (based on inoculum received)
and are alive and healthy, with the exception of two AHQ/
AHQ animals which received AHQ/AHQ inoculum (a dif-
ferent source inoculum from the one used in the success-BMC Veterinary Research 2007, 3:20 http://www.biomedcentral.com/1746-6148/3/20
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ful transmission reported in this paper), which are
showing neurological abnormalities at approx 860 dpi.
Clinical assessments
Animals were monitored daily during routine husbandry
procedures (feeding, bedding) and weighed monthly. If
clinical disease was suspected the animals were examined
clinically and neurologically [26], which included testing
of the scratch reflex to assess if a stereotypical response
('nibble reflex') could be elicited [15]. Prior to cull, ani-
mals were also monitored by CCTV for signs of pruritus
(scratching, rubbing or nibbling body parts) or other
behavioural abnormalities.
At clinical end-point, animals were killed using quinalbar-
bitone sodium (Somulose, Arnolds) and tissues collected
into formal saline (for central nervous system tissues),
neutral buffered formalin or stored frozen at -80°C. The
brain was divided in half, with one half placed in fixative,
and the other half stored frozen.
Western Blotting
Fresh brain samples (either frontal cortex, or medulla)
were subjected to the TeSeE sheep/goat Western blot (Bio-
Rad Cat No: 355 1169). Tissue (0.35 g) from each sample
was ribolysed, purified, PK treated and PrPres concentrated
following the kit instructions and reagents supplied. Sam-
ples were heated for 4 mins at 100°C prior to loading on
gels. ECL DualVue (Amersham) molecular mass markers
were included at either end of the gel. A single lane each
of a UK classical ovine scrapie, UK bovine BSE and a
Nor98 ovine scrapie case were included for profile com-
parisons. Fifteen microlitres of each sample (tissue equiv-
alent of 0.02 g) was loaded in duplicate lanes onto pre-
cast 12% bis-tris gels (Criterion) and electrophoresed for
50 mins at 200 V. The proteins were then transferred onto
PVDF membranes (115 V for 60 min) and blocked (Bio-
Rad blocking solution) for 40 mins at room temperature.
They were probed with the kit primary antibody (mono-
clonal antibody SHA31, diluted to 1:10 of the supplied kit
concentration) for 30 mins at room temperature. The
membranes were washed, incubated for 20 mins in Bio-
Rad secondary antibody at room temperature, washed
again and the membranes were incubated with ECL sub-
strate (Amersham) for 45 secs – 1 min. The signal was
detected with the Fluor-S MultiImager (Bio-Rad).
Immunohistochemistry
Immunohistochemical detection of PrPSc was performed
using mouse Mab 2G11 (Institute Pourquier), raised
against ovine PrP peptide sequence 146-R154R171-182.
Tissue sections were de-waxed and rehydrated routinely.
Epitope demasking was performed by immersion of sec-
tions for 30 minutes in undiluted formic acid, then
washed in running tap water for 15 minutes, followed by
autoclaving at 121°C in citrate buffer pH 6.1 (8.8 mM tri-
sodium citrate dihydrate, 1.3 mM citric acid in 2 litres
purified water). Endogenous peroxidase was blocked
using 3% hydrogen peroxide (100 vol) in methanol, and
washing buffer used throughout the procedure was tris
buffered saline, supplemented with 0.2% tween20
(TBST). Primary antibody was applied at dilution of 1/
400 for one hour at room temperature, with immunode-
tection performed using biotinylated goat anti mouse and
avidin-biotin-peroxidase-complex (Vector Elite) tech-
nique using diaminobenzidine chromogen prepared in
McIlvane's citrate buffer. Sections were counterstained
using Mayers haematoxylin, then routinely dehydrated,
cleared and mounted in dibutylphthalate in xylene
(DPX), before examination by light microscopy.
Abbreviations
CCTV Closed circuit television
CJD Creutzfeldt-Jakob disease
dpi days post inoculation
DPX dibutylphthalate in xylene
ECL Enhanced chemiluminescence
EFSA European Food Safety Authority
EU European Union
FFI Fatal familial insomnia
GSS Gerstmann-Sträussler-Scheinker disease
LRS Lymphoreticular system
Mab Monoclonal antibody
PK proteinase K
PrP prion protein
PrPres Proteinase K resistant, disease-associated prion pro-
tein
PrPSc PrP scrapie – the disease-associated isoform of prion
protein
PVDF polyvinylidene fluoride
TSE transmissible spongiform encephalopathy
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